Trial intelligence / Profile preview

Metoprolol for Prevention of Vasovagal Syncope in Older Adults

2015-000284-14Phase 3Unknown

Sponsor
University of Calgary
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in Neurocardiogenic syncope (NCS) comparing Metoprolol with Placebo (2 arms). Primary endpoint: Time to first recurrence of syncope. Status: unknown.

02

Drugs

metoprolol
03

Conditions

Neurocardiogenic syncope (NCS)

Beyond the preview

Go deeper on 2015-000284-14.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-000284-14.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call